Showing results (111-120 of 375) with videos related to
Sort By:
Pageof 38
Diabetes, Obesity & Metabolism|June 12, 2009
Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed miceN Irwin, P L McClean, K Hunter, et al.Clinical Pharmacology and Therapeutics|May 13, 2015
The Current Drug Treatment Landscape for Diabetes and Perspectives for the FutureC J BaileyDiabetes, Obesity & Metabolism|October 13, 2005
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinedionesC J BaileyBiochemical Pharmacology|January 26, 1993
Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteinsC R Barnett, S Rudd, P R Flatt, et al.European Journal of Pharmacology|December 7, 1995
Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker ratA Irizar, C R Barnett, P R Flatt, et al.Diabetes Research (Edinburgh, Scotland)|February 1, 1990
Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cellsP R Flatt, O Shiber, S M Hampton, et al.Molecular and Cellular Endocrinology|December 3, 2014
Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed miceV Pathak, V A Gault, P R Flatt, et al.Endocrinology|October 1, 1980
Calcium and pancreatic beta-cell function. IX. Demonstration of lanthanide-induced inhibition of insulin secretion independent of modifications in transmembrane Ca2+ fluxesP R Flatt, P O Berggren, E Gylfe, et al.Pageof 38